Navigation Links
Asthma and eczema sufferers have a lower risk of developing a cancer
Date:7/20/2010

This press release is available in French.

Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRSInstitut Armand-Frappier, the Research Centre of the Centre hospitalier de l'Universit de Montral, and McGill University. The findings, published in the Annals of Allergy, Asthma & Immunology, show that male eczema sufferers had a lower risk of lung cancer while those with a history of asthma had a similar effect in relation to stomach cancer.

"Asthma and eczema are allergies brought about by a hyper-reactive immune system a state which might have enabled abnormal cells to have been eliminated more efficiently, thereby reducing the risk of cancer," explained Professor Marie-Claude Rousseau of the INRSInstitut Armand-Frappier, one of the co-authors of the research.

The researchers analyzed information that was collected in a study on exposures in the workplace and the risk of developing cancer, undertaken between August 1979 and March 1986. It involved 3,300 men, between 35 and 70 years of age, who had been diagnosed with cancer in one of Montreal's 18 hospitals, and a control group of 512 people from the general population who did not have cancer. The researchers used the data from this study to determine if there was a link between allergies such as asthma and eczema and the incidence of eight most common types of cancer.

These findings contribute important knowledge to population health and provide new research leads. Although the study did not allow to identify which specific factors related to asthma and eczema were responsible for reducing the risk of cancer, it offers new angles for research into the molecular and immunological mechanisms that are involved in immunostimulation, a potentially promising strategy for cancer prevention.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Related biology news :

1. RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
2. Pregnant women with asthma can be more confident about some medicines
3. New asthma research opposes current drug treatment, says UH prof
4. Fast-food diet cancels out benefits of breastfeeding in preventing asthma
5. Eosinophils as markers for asthma
6. Indoor air pollution increases asthma symptoms
7. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
8. Airborne asthma allergens
9. Vitamin D levels linked to asthma severity
10. Athletes with asthma need more help from their team trainers
11. Alzheimers, asthma, cancer, malaria and TB focus of new Singapore grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
Breaking Biology Technology: